Ozempic Wars | The Hundred-Year Duel | 1
Business Wars19 Nov 2025

Ozempic Wars | The Hundred-Year Duel | 1

When pharmaceutical giant Novo Nordisk developed a new medication for type 2 diabetes, they noticed that a welcome side effect was a small amount of weight loss. They had no idea that their new diabetes medication was about to become a multibillion-dollar weight loss drug. But they had no sooner launched this game-changing drug, then competitors swooped in to knock Novo Nordisk off its throne.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episoder(665)

How Nvidia Owned A.I. | Light Speed or Bust | 1

How Nvidia Owned A.I. | Light Speed or Bust | 1

It’s the early 1990s and video games are about to go 3D. And in a Denny’s in Silicon Valley, three engineers are plotting to cash in on the transition with a startup called Nvidia. But when they misju...

17 Des 202544min

The Many Deaths of Dungeons & Dragons | Game On | 3

The Many Deaths of Dungeons & Dragons | Game On | 3

Fifty years after its inception, Dungeons & Dragons has become more than just a fantasy game for nerds. It’s a cultural phenomenon, thanks in part to Netflix’s “Stranger Things” and livestream channel...

11 Des 202539min

The Many Deaths of Dungeons & Dragons | A Kingdom Reborn | 2

The Many Deaths of Dungeons & Dragons | A Kingdom Reborn | 2

After years of falling sales, Dungeons & Dragons’ publisher TSR is being dragged under by massive debts and in need of rescue. But as hopelessness takes hold, TSR boss Lorraine Williams resorts to des...

10 Des 202538min

The Many Deaths of Dungeons & Dragons | Wizards and Witch Hunts | 1

The Many Deaths of Dungeons & Dragons | Wizards and Witch Hunts | 1

When Gary Gygax and his gaming pal Dave Arneson create Dungeons & Dragons, he believes he’s onto something special and starts a business called TSR to publish it. But when TSR publishes the game, he m...

3 Des 202543min

Ozempic Wars | The Next Injection | 2

Ozempic Wars | The Next Injection | 2

Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Lay...

26 Nov 202536min

Gap's Revival | Better in Navy?  | 3

Gap's Revival | Better in Navy? | 3

The “Better in Denim” ad campaign put Gap back on the map for Gen Z — but are viral ads enough to fuel a comeback? Jordyn Holman of the New York Times breaks down how Gap CEO Richard Dickson is taking...

13 Nov 202539min

Gap's Revival | Back in Blue | 2

Gap's Revival | Back in Blue | 2

It’s late 2023, and Gap’s new CEO Richard Dickson is trying to revive the brand’s fading fortunes. Dickson is the man who rescued Barbie from cultural irrelevance and turned her into a blockbuster mov...

12 Nov 202538min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
e24-podden
finansredaksjonen
pengepodden-2
pengesnakk
rss-sunn-okonomi
morgenkaffen-med-finansavisen
stormkast-med-valebrokk-stordalen
tid-er-penger-en-podcast-med-peter-warren
rss-markedspuls-2
livet-pa-veien-med-jan-erik-larssen
rss-investering-gjort-enkelt
utbytte
liberal-halvtime
okonomiamatorene
lederskap-nhhs-podkast-om-ledelse